Quarterly report pursuant to Section 13 or 15(d)

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

v3.24.3
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
9 Months Ended
Sep. 30, 2024
Sep. 30, 2023
Cash flows from operating activities    
Net income (loss) $ 132,316 $ 59,767
Adjustments to reconcile net income (loss) to net cash provided by operating activities:    
Provision for loss on receivables (944) 12,481
Depreciation and amortization 690 2,746
Amortization of financing costs 12,994 9,347
Equity-based compensation 19,002 14,977
Equity method investments (122,042) (937)
Non-cash gain on securitization (58,978) (34,080)
(Gain) loss on sale of receivables and investments 7,717 1,305
Changes in receivables held-for-sale (16,763) 40,183
Changes in accounts payable and accrued expenses 69,357 8,952
Change in accrued interest on receivables and investments (52,244) (26,087)
Cash received (paid) upon hedge settlement 19,261 0
Other 7,689 3,686
Net cash provided by (used in) operating activities 18,055 92,340
Cash flows from investing activities    
Equity method investments (200,202) (583,323)
Equity method investment distributions received 26,705 20,259
Proceeds from sales of equity method investments 2,107 0
Purchases of and investments in receivables (501,548) (1,016,467)
Principal collections from receivables 508,704 167,406
Proceeds from sales of receivables 124,150 7,634
Proceeds from sale of real estate 115,767 0
Purchases of investments and securitization assets (10,537) (14,404)
Posting of hedge collateral (26,380) 0
Receipt of hedge collateral 16,150 0
Other (845) (285)
Net cash provided by (used in) investing activities 54,071 (1,419,180)
Cash flows from financing activities    
Proceeds from credit facilities 831,792 777,000
Principal payments on credit facilities (1,116,792) (342,000)
Proceeds from issuance of term loan 250,000 200,000
Principal payments on term loan (563,148) (9,575)
Proceeds from issuance of commercial paper notes 0 49,775
Principal payments on commercial paper notes (12,000) 0
Proceeds from issuance of senior unsecured notes 900,355 0
Proceeds from issuance of convertible notes 0 402,500
Principal payments on convertible notes 0 (143,748)
Purchase of capped calls related to the issuance of convertible notes 0 (37,835)
Redemption of senior unsecured notes (400,000) 0
Net proceeds of common stock issuances 179,722 465,015
Payments of dividends and distributions (142,178) (115,087)
Withholdings on employee share vesting (502) (1,466)
Payment of financing costs (27,100) (13,302)
Posting of hedge collateral (134,150) 0
Receipt of hedge collateral 124,700 106,330
Other (969) (2,493)
Net cash provided by (used in) financing activities (88,572) 1,320,400
Increase (decrease) in cash, cash equivalents, and restricted cash (16,446) (6,440)
Cash, cash equivalents, and restricted cash at beginning of period 75,082 175,972
Cash, cash equivalents, and restricted cash at end of period 58,636 169,532
Supplemental disclosure of non-cash activity    
Interest paid 142,808 91,988
Residual assets retained from securitization transactions 31,662 26,020
Equity method investments retained from securitization and deconsolidation transactions 32,564 144,603
Equity method investments retained from sale of assets upon establishment of co-investment structure 54,655 0
Deconsolidation of non-recourse debt 51,233 257,746
Deconsolidation of assets pledged for non-recourse debt 51,761 374,608
Non-recourse debt    
Cash flows from financing activities    
Proceeds from issuance of non-recourse debt 94,000 0
Principal payments on non-recourse debt $ (72,302) $ (14,714)